GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) » Definitions » Forward Dividend Yield %

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Forward Dividend Yield % : 0.63% (As of May. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wuhan Easy Diagnosis Biomedicine Co Forward Dividend Yield %?

As of today (2024-05-25), the Forward Annual Dividend Yield of Wuhan Easy Diagnosis Biomedicine Co is 0.63%.

As of today (2024-05-25), the Trailing Annual Dividend Yield of Wuhan Easy Diagnosis Biomedicine Co is 19.48%.

SZSE:002932's Forward Dividend Yield % is ranked worse than
85.06% of 308 companies
in the Medical Devices & Instruments industry
Industry Median: 1.96 vs SZSE:002932: 0.63

Wuhan Easy Diagnosis Biomedicine Co's Dividends per Share for the three months ended in Mar. 2024 was ¥0.00.

During the past 12 months, Wuhan Easy Diagnosis Biomedicine Co's average Dividends Per Share Growth Rate was 22.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 387.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 141.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Wuhan Easy Diagnosis Biomedicine Co was 387.20% per year. The lowest was 117.00% per year. And the median was 214.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Wuhan Easy Diagnosis Biomedicine Co's Forward Dividend Yield %

For the Medical Devices subindustry, Wuhan Easy Diagnosis Biomedicine Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Easy Diagnosis Biomedicine Co's Forward Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wuhan Easy Diagnosis Biomedicine Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Wuhan Easy Diagnosis Biomedicine Co's Forward Dividend Yield % falls into.



Wuhan Easy Diagnosis Biomedicine Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Wuhan Easy Diagnosis Biomedicine Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CNY 3.7000002023-06-062023-06-052023-06-06Cash Dividendsemi-annuallyCNY:CNY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Wuhan Easy Diagnosis Biomedicine Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=7.4/18.99
=38.97 %

Current Share Price is ¥18.99.
Wuhan Easy Diagnosis Biomedicine Co's Dividends per Share for the forward twelve months is calculated as ¥3.7 * 2 = ¥7.4.

Wuhan Easy Diagnosis Biomedicine Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=3.7/18.99
=19.48 %

Current Share Price is ¥18.99.
Wuhan Easy Diagnosis Biomedicine Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥3.7.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan Easy Diagnosis Biomedicine Co  (SZSE:002932) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Wuhan Easy Diagnosis Biomedicine Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Wuhan Easy Diagnosis Biomedicine Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Dongxin Road, 2 Floor, Building E, International Students Pioneer Park, Guandong Science and Technology Park, Donghu Development Zone, Hubei, Wuhan, CHN, 430075
Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.
Executives
Wang Rui Directors, executives
Wang Jian Fei Director

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Headlines

No Headlines